SOAT1 and inflammatory bowel disease: Furthermore, with the implication of the JAK-STAT signaling pathway in patients with pCD [18] and the evolution of JAK inhibitor therapy in inflammatory bowel disease (IBD), small molecules may play a key role in the future medical management of pCD.